Previous Article | Next Article ![]()
Journal of Virology, May 2001, p. 4551-4557, Vol. 75, No. 10
Division of Cellular and Gene
Therapies1 and Division of Viral
Products,2 Center for Biologics Evaluation
and Research, Food and Drug Administration, Bethesda, Maryland
Received 13 October 2000/Accepted 5 February 2001
The pig genome contains porcine endogenous retroviruses (PERVs)
capable of infecting human cells. Detection of infectious retrovirus in porcine peripheral blood mononuclear cells and
endothelial cells suggested to us that pig plasma is likely to contain
PERV. Both PERV env sequences and viral reverse
transcriptase (RT) activity were detected in all plasma samples
isolated from four NIH minipigs. To detect infectious virus from
plasma, we performed a culture assay using three cell lines of feline,
swine, and human origin that had previously been shown to be
permissive for PERV. Infectious virus was successfully cultured from
all four NIH minipig plasmas on the swine cell line ST-IOWA. Using
RT-PCR with env-specific primers, we could detect
expression of PERV class C envelope in the supernatant of ST-IOWA cells
that had been exposed to each pig plasma. We next examined a pig plasma
derivative, Hyate:C (porcine factor VIII), and found evidence of PERV
particles, since all six lots examined were positive for PERV RNA and
RT activity. However, infectious virus could not be detected in
clinical lots of Hyate:C, suggesting that the manufacturing process
might reduce the load of infectious virus to levels below detectable
limits of the assay. Detection of infectious virus in porcine plasma confirms and extends the previous findings that certain porcine cells
express PERV when manipulated in vitro and clearly demonstrates that there are porcine cells that express infectious PERV
constitutively in vivo.
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.10.4551-4557.2001
Detection and Characterization of Porcine Endogenous
Retrovirus in Porcine Plasma and Porcine Factor VIII
*
Corresponding author. Mailing address: CBER, FDA,
Building 29B, Room NN11, 8800 Rockville Pike, Bethesda, MD 20892. Phone: (301) 827-0481. Fax: (301) 827-0449. E-mail:
wilsonc{at}cber.fda.gov.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|